As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA), tirzepatide produces synergistic effects like increased insulin production and release, which gives it an edge over strict GLP-1 receptor agonist such as semaglutide (Ozempic)
This is why research into complex conditions is so challenging
Anti-Inflammatory Effects The peptide reduced pro-inflammatory cytokines by 50% in vitro, potentially mitigating inflammation-related hair loss (Maat et al., 2009)
& Chattopadhyay, S
Fatigue can come from sleep, thyroid status, anemia, mood, medications, nutrition, or chronic disease
In cases of Graves disease, treatment can include antithyroid medications such as methimazole or PTU, which impede thyroid hormone synthesis (Brandfon et al